^
BIOMARKER:

ARID1A mutation

i
Other names: ARID1A, AT-Rich Interaction Domain 1A, SWI/SNF-Related, Matrix-Associated, Actin-Dependent Regulator Of Chromatin Subfamily F Member 1, AT-Rich Interactive Domain-Containing Protein 1A, AT Rich Interactive Domain 1A (SWI-Like), ARID Domain-Containing Protein 1A, SWI/SNF Complex Protein P270, BRG1-Associated Factor 250a, SWI-Like Protein, Osa Homolog 1, SMARCF1, C1orf4, BAF250, HOSA1, OSA1, AT Rich Interactive Domain 1A (SWI- Like), Chromatin Remodeling Factor P250, BRG1-Associated Factor 250, OS




Show legend

Include preclinical:
Ovarian Cancer
Non Small Cell Lung Cancer
Endometrial Cancer
Cholangiocarcinoma
Renal Cell Carcinoma
Bladder Cancer
Hepatocellular Cancer
Gastric Cancer
Urothelial Cancer
Lymphoma
Esophageal Adenocarcinoma
Gastrointestinal Cancer
Head and Neck Cancer
Breast Cancer
Endometrial Adenocarcinoma
Pancreatic Ductal Adenocarcinoma
Melanoma
Neuroendocrine Tumor
Solid Tumor
Cervical Cancer
Non-Hodgkin’s Lymphoma
Colorectal Cancer
CPI-0209
NXP900
durvalumab + tremelimumab
sunitinib
bevacizumab + rucaparib
chidamide
toripalimab-tpzi
NXP800
AZD6738
sintilimab
gemcitabine
pembrolizumab + anlotinib
OTX015
cetuximab
cisplatin + gemcitabine
GSK2816126
Immunotherapy
PD1 inhibitor + Angiogenesis inhibitor
PD1 inhibitor
CAR-T immunotherapy
EZH2 inhibitor